HealthTree Foundation for Multiple Myeloma
14K subscribers
HealthTree University for Multiple Myeloma provides trusted, patient-friendly education featuring leading myeloma specialists and healthcare experts. Find answers to common questions about myeloma diagnosis, testing, risk, treatment, relapse, side effects, and new therapies. Learn how FISH, karyotyping, next-generation sequencing (NGS), gene expression profiling (GEP), bone marrow biopsy, PET/CT, MRI, blood tests, and minimal residual disease (MRD) are used in myeloma care. Explore multiple myeloma treatments including daratumumab, lenalidomide, stem cell transplant, CAR T-cell therapy, bispecific antibodies, IMiDs, CELMoDs, clinical trials, and treatments for relapsed or refractory myeloma. HealthTree University turns complex medical information into clear education to help patients and caregivers understand their disease, test results, treatment options, and questions to ask their healthcare team. HealthTree University is part of HealthTree Foundation for Multiple Myeloma

Do All Myeloma Patients Need Bone Strengthening Treatment?
HealthTree Foundation for Multiple Myeloma · 1.3K views · 1 year ago

Your Multiple Myeloma Lab Results, Decoded: What They Mean and What They Don’t
HealthTree Foundation for Multiple Myeloma · 5.2K views · 5 months ago

How Doctors Identify High-Risk Multiple Myeloma (HRMM) Using Genetics
HealthTree Foundation for Multiple Myeloma · 2.6K views · 1 year ago

What Is Multiple Myeloma?
HealthTree Foundation for Multiple Myeloma · 11K views · 1 year ago

Beyond remission—what are the true goals of myeloma treatment?
HealthTree Foundation for Multiple Myeloma · 1.1K views · 1 year ago

Blood Clots and Myeloma: What You Need to Know
HealthTree Foundation for Multiple Myeloma · 528 views · 5 months ago

Myeloma Treatments Explained: Targeted vs. Traditional Chemotherapy
HealthTree Foundation for Multiple Myeloma · 533 views · 5 months ago

Understanding Your Myeloma Labs: What They Mean, What Matters, and When to Ask Questions
HealthTree Foundation for Multiple Myeloma · 2.5K views · 3 months ago

Nashville Roundtable Audience Q&A with Faculty #myeloma
HealthTree Foundation for Multiple Myeloma · 318 views · 6 months ago

Upfront or delayed stem cell transplant: What factors tip the scales? #myeloma
HealthTree Foundation for Multiple Myeloma · 1.9K views · 1 year ago

Real-World Treatment Sequencing After CAR-T vs Bispecific Antibodies in Multiple Myeloma | EHA 2026
HealthTree Foundation for Multiple Myeloma · 207 views · 2 months ago

How common is myeloma in the U.S- Incidence and Prevalence
HealthTree Foundation for Multiple Myeloma · 796 views · 1 year ago